Restart Life Sciences Corp.
NMLSF
$0.07
-$0.01-14.29%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -647.60K | -983.60K | -870.70K | -380.60K | -299.70K |
| Total Depreciation and Amortization | 3.80K | 1.20K | 1.30K | 1.40K | 1.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 330.50K | 661.20K | 485.60K | 31.80K | -3.10K |
| Change in Net Operating Assets | -86.90K | -189.70K | 98.30K | 115.90K | 118.80K |
| Cash from Operations | -400.20K | -510.80K | -285.40K | -231.40K | -182.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -607.40K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -607.40K | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | 250.00K | 15.00K | 15.00K | 15.00K |
| Total Debt Repaid | -5.00K | -83.00K | -83.00K | -83.00K | -83.00K |
| Issuance of Common Stock | 2.06M | 2.14M | 550.00K | 550.00K | 550.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.80K | -- | -- | -- | -- |
| Cash from Financing | 1.65M | 1.64M | 336.10K | 336.10K | 336.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 643.00K | 1.13M | 50.60K | 104.60K | 153.60K |